Archive: 31/08/2016

CRISPR/Cas9 technology to inactivate cancer mutations

As for many other biomedical and biotechnology disciplines, the genome scissor "CRISPR/Cas9" also opens up completely new possibilities for cancer research. Scientists of the National Center for Tumor Disease (NCT), the German ...

page 6 from 9